Article: Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleOverexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo
AuthorsZheng, L1
Lam, WK1
Tipoe, GL1
Shum, IH1
Yan, C1
Leung, R1
Sun, J1
Ooi, GC1
Tsang, KW1
KeywordsBronchial Biopsy
Bronchiectasis
Matrix Metalloproteinase
Neutrophils
Issue Date2002
PublisherEuropean Respiratory Society. The Journal's web site is located at http://erj.ersjournals.com
CitationEuropean Respiratory Journal, 2002, v. 20 n. 1, p. 170-176 [How to Cite?]
DOI: http://dx.doi.org/10.1183/09031936.02.00282402
AbstractThe progressive bronchial dilatation in bronchiectasis is likely to be the result of continued airway matrix destruction, although little is known about the role of neutrophil matrix metalloproteinases (MMPs) in this process. Immunohistochemistry has been used to investigate the expression and cellular localisation of MMP-8 and MMP-9 in bronchiectatic airways in vivo. Endobronchial biopsies were taken from 25 bronchiectatic patients, and from the right lower lobe in 14 control subjects. MMP-8, MMP-9, neutrophils and macrophages were stained with monoclonal antibodies and quantified as positive cell·mm -2 of the lamina propria by using an image analysis system. There were significantly higher densities of MMP-8 and MMP-9 positive cells in the lamina propria of bronchiectatic than control airways. In bronchiectatic airways, the densities of MMP-8 and MMP-9 positive cells correlated with each other and with neutrophil density, but not with macrophage density. In control airways, a significant correlation was found between MMP-8 with neutrophil and MMP-9 with macrophage densities. An overexpression of neutrophil matrix metalloproteinases in bronchiectatic airways could help explain the continuation of airway destruction in bronchiectasis. In view of the clinical availability of matrix metalloproteinase antagonists, the results presented here could have a significant impact on the development of novel therapies of this untreatable disease.
ISSN0903-1936
2011 Impact Factor: 5.895
2011 SCImago Journal Rankings: 0.466
DOIhttp://dx.doi.org/10.1183/09031936.02.00282402
ISI Accession Number IDWOS:000177188600028
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorZheng, L
dc.contributor.authorLam, WK
dc.contributor.authorTipoe, GL
dc.contributor.authorShum, IH
dc.contributor.authorYan, C
dc.contributor.authorLeung, R
dc.contributor.authorSun, J
dc.contributor.authorOoi, GC
dc.contributor.authorTsang, KW
dc.date.accessioned2012-06-26T05:55:51Z
dc.date.available2012-06-26T05:55:51Z
dc.date.issued2002
dc.description.abstractThe progressive bronchial dilatation in bronchiectasis is likely to be the result of continued airway matrix destruction, although little is known about the role of neutrophil matrix metalloproteinases (MMPs) in this process. Immunohistochemistry has been used to investigate the expression and cellular localisation of MMP-8 and MMP-9 in bronchiectatic airways in vivo. Endobronchial biopsies were taken from 25 bronchiectatic patients, and from the right lower lobe in 14 control subjects. MMP-8, MMP-9, neutrophils and macrophages were stained with monoclonal antibodies and quantified as positive cell·mm -2 of the lamina propria by using an image analysis system. There were significantly higher densities of MMP-8 and MMP-9 positive cells in the lamina propria of bronchiectatic than control airways. In bronchiectatic airways, the densities of MMP-8 and MMP-9 positive cells correlated with each other and with neutrophil density, but not with macrophage density. In control airways, a significant correlation was found between MMP-8 with neutrophil and MMP-9 with macrophage densities. An overexpression of neutrophil matrix metalloproteinases in bronchiectatic airways could help explain the continuation of airway destruction in bronchiectasis. In view of the clinical availability of matrix metalloproteinase antagonists, the results presented here could have a significant impact on the development of novel therapies of this untreatable disease.
dc.description.naturelink_to_OA_fulltext
dc.identifier.citationEuropean Respiratory Journal, 2002, v. 20 n. 1, p. 170-176 [How to Cite?]
DOI: http://dx.doi.org/10.1183/09031936.02.00282402
dc.identifier.doihttp://dx.doi.org/10.1183/09031936.02.00282402
dc.identifier.epage176
dc.identifier.isiWOS:000177188600028
dc.identifier.issn0903-1936
2011 Impact Factor: 5.895
2011 SCImago Journal Rankings: 0.466
dc.identifier.issue1
dc.identifier.pmid12166566
dc.identifier.scopuseid_2-s2.0-0035989381
dc.identifier.spage170
dc.identifier.urihttp://hdl.handle.net/10722/149605
dc.identifier.volume20
dc.languageeng
dc.publisherEuropean Respiratory Society. The Journal's web site is located at http://erj.ersjournals.com
dc.publisher.placeSwitzerland
dc.relation.ispartofEuropean Respiratory Journal
dc.relation.referencesReferences in Scopus
dc.subjectBronchial Biopsy
dc.subjectBronchiectasis
dc.subjectMatrix Metalloproteinase
dc.subjectNeutrophils
dc.titleOverexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong